Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: results from the BioDay registry.

Esmé Kamphuis Laura Loman Henry L HanG L E RomeijnK PolitiekMarie-Louise A Schuttelaar

Published in: Contact dermatitis (2023)

Upadacitinib can be an effective treatment for patients with AD and concomitant HE in daily practice. Future studies should focus on the effectiveness of upadacitinib on chronic HE, especially on the different etiological subtypes of HE, including HE in non-atopic individuals. This article is protected by copyright. All rights reserved.

Keyphrases

atopic dermatitis
healthcare
primary care
randomized controlled trial
physical activity
systematic review
mental health
quality improvement